CETP and cancer: Table 1 presents both preliminary and clinical studies that have highlighted the pleiotropic benefits of CETP inhibition beyond CVD risk assessment. Subsequently, Figure 2 depicts proposed anti-cancer mechanisms of action of CETP inhibitors, PCSK9 inhibitors, and bempedoic acid, as reported in experimental studies in recent years.